Floatz logo

2 assets in Primary Cutaneous Gamma-Delta T-Cell Lymphoma

Therapeutic assets addressing Primary Cutaneous Gamma-Delta T-Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Immunoglobulin G1, Anti-(Human/Macaca Fascicularis/Macaca Mulatta Killer Cell Lectin-Like Receptor Klrd1) (Human Monoclonal Dr-01 ?1-Chain), Disulfide With Human Monoclonal Dr-01 ?-Chain, Dimer
Primary Cutaneous Gamma-Delta T-Cell Lymphoma
Dren BioP1/2CCC (48)
Wu-Cart-007
Primary Cutaneous Gamma-Delta T-Cell Lymphoma
Washington University School of MedicineP1CC (43)